1. Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: Results from a multicenter Italian experience
- Author
-
Azeem Latib, Giulio Bonzani, Antonio Colombo, Alfonso Ielasi, Bernardo Cortese, Elisabetta Moscarella, Bruno Trimarco, Eugenio Stabile, Paolo Calabrò, Attilio Varricchio, Maurizio Tespili, Anna Franzone, Francesco Granata, Vasileios F. Panoulas, Giovanni Esposito, Moscarella, Elisabetta, Varricchio, Attilio, Stabile, Eugenio, Latib, Azeem, Ielasi, Alfonso, Tespili, Maurizio, Cortese, Bernardo, Calabro', Paolo, Granata, Francesco, Panoulas, Vasileios F, Franzone, Anna, Trimarco, Bruno, Bonzani, Giulio, Esposito, Giovanni, and Colombo, Antonio
- Subjects
Male ,medicine.medical_specialty ,Restenosi ,Coronary Angiography ,law.invention ,Cohort Studies ,Coronary Restenosis ,Blood Vessel Prosthesis Implantation ,Percutaneous Coronary Intervention ,Randomized controlled trial ,law ,Absorbable Implants ,Stent ,Humans ,Medicine ,Prospective Studies ,Angioplasty, Balloon, Coronary ,Aged ,Bioresorbable vascular scaffold ,Aged, 80 and over ,business.industry ,Drug-Eluting Stents ,Middle Aged ,medicine.disease ,DES ,Thrombosis ,Surgery ,BVS ,Treatment Outcome ,Italy ,Conventional PCI ,Female ,Stents ,Radiology ,In stent restenosis ,Cardiology and Cardiovascular Medicine ,business ,Follow-Up Studies - Abstract
This multicenter experience sought to investigate the feasibility and safety of BVS for the treatment of ISR. From April 2012 to June 2014, a total of 315 patients (334 lesions) underwent PCI for ISR at the participating centers. Of those, 83 patients (90 lesions) received BVS. Procedural success was achieved in all patients. At a median of 7 (IQR 3–18) months follow-up, MACCE rate was 12%, TLR 7.7%, while one (1.1%) definite BVS-in-stent thrombosis was reported. The results of this multicenter experience suggest that BVS implantation for the treatment of coronary ISR is technically feasible and associated with favorable mid-term clinical results. These data could be considered hypothesis generating for a future randomized clinical trial.
- Published
- 2015
- Full Text
- View/download PDF